Thynk Capital, LLC. Company
Thynk Capital possess a historical investment performance in the top 1% of venture capital. Focused on investments in early stage pharma and biotech companies focused on extending HealthSpan and major diseases of Aging including Alzheimer's, Dementia, Kidney Disease, Cancer, Cardiovascular, Diabetes, Frailty, and Rare Disease which affect over 25% of the population and growing at 10%/year.
Industry:
Biotechnology, Health Care
Number Of Exists:
1
Technology:
Geroscience
Founded Date:
2011-03-04
Investor Type:
For Profit
Headquarters:
Las Vegas, Nevada, United States
Employee Number:
1-10